London-based MintNeuro, a semiconductor company building specialized chips for neural devices from implants to wearables, announced a US$5 million investment round to support its commercial scale-up. The company said the new capital will accelerate product launches, expand delivery of pre-release silicon to partners, and grow its international presence. The funding brings together investors from Europe and the United States and marks a transition from technology validation toward broader commercial deployment.
Investor Backing and Strategic Purpose
The round was led by Odyssey Ventures, with participation from 33East, JSK Investments, and Alumni Ventures. Returning investors include Empirical Ventures, Jumpspace Ventures, and existing early backers. The syndicate combines deep tech, medtech, and early-stage investors, reflecting demand for scalable hardware that can support the growth of neurotechnology.
Technology Platform and Market Need
MintNeuro provides a modular semiconductor platform designed for core functions such as neural sensing, signal processing, and stimulation. The company said developers have historically faced a tradeoff between generic components that were never designed for the body and years of custom chip development. Its chips aim to enable smaller, lower-power neural devices and help innovators move from research to clinical use sooner.
Partnerships and Commercial Progress
MintNeuro has already delivered working silicon and reached integration milestones with research and development partners such as Motif Neurotech and Amber Therapeutics. Earlier this year, the company announced a partnership and multi-year commercial chip supply agreement with Motif, supporting the development of a minimally invasive neurostimulator initially targeting treatment-resistant depression. A growing number of neural device companies are now evaluating or integrating MintNeuro's technology, alongside research teams building implantable systems that connect directly to the brain and nervous system.
Use of Proceeds and Global Expansion
MintNeuro will use the investment to grow its engineering and commercial teams and to bring its products to market. The company also plans to support customers as they adopt its chips and to strengthen its presence in the United States alongside its United Kingdom and European base. These efforts are intended to accelerate product launch, partner adoption, and international expansion.
Leadership Perspectives
Dorian Haci, co-founder and chief executive officer of MintNeuro, said every neural device depends on the chips inside it, and developers have historically faced a choice between generic components and custom silicon development. He said the funding moves the company from technology validation to commercial scale-up, with more customer programs, faster product launches, and chips in the hands of more developers. Haci added that the company's ambition is to become the semiconductor platform the global neurotechnology industry builds on.
Michelle Robson, founding partner at Odyssey Ventures, said neural devices such as brain-computer interfaces represent one of the most exciting frontier technology opportunities today. Yiannis Eftychiou, co-founder and partner at 33East, highlighted the breadth of the hardware opportunity, from neural implants to wearables and beyond. Johnathan Matlock, co-founder and general partner at Empirical Ventures, said the firm reinvested after seeing working silicon, customer traction, and a clear path to a category-defining semiconductor business.
Founded as a spinout from Imperial College London, MintNeuro is initially focused on medical applications where size, power, reliability, and safety are critical. Professor Tim Denison, chair of MintNeuro, said specialized hardware will determine how far and how fast neurotechnology can advance. By removing the need for custom chip development or adapted generic components, MintNeuro aims to become the industry standard semiconductor platform for brain-computer interfaces, bioelectronic medicine, and other neural technologies.